<?xml version="1.0"  ?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
<channel>
  <title>HITeducation.com</title>
  <link>http://www.HITeducation.com</link>
  <language>en-us</language>
  <itunes:author>HITeducation.com - The France Foundation</itunes:author>
  <itunes:summary>HITeducation.com CME Peer-to-Peer Dialogue features insightful audio commentary from a multidisciplinary group of experts in hematology, emergency medicine, and critical care nursing. Listen in for state-of-the-art information as they address timely, clinically relevant topics identified by the HITeducation.com faculty. Visit www.HITeducation.com to apply for CME Credit.</itunes:summary>
  <description>Heparin-induced thrombocytopenia (HIT) is a serious complication that can arise as a result of heparin-based antithrombotic therapy, characterized by low platelet counts with a paradoxical high risk of thrombosis. If it goes unrecognized, HIT has potentially devastating consequences, including amputation and even death, due to thromboembolic events. Guidelines for HIT emphasize careful screening of platelet counts in at-risk patients, immediate cessation of heparin if a drop in platelet count is detected, and immediate substitution with an alternative antithrombotic therapy. Adherence to these guidelines requires an astute awareness of HIT, its clinical presentation and diagnosis, and its proper management among hospital-based caregivers. Visit www.HITeducation.com to learn more.</description>
  <itunes:owner>
     <itunes:name>HITeducation.com</itunes:name>
     <itunes:email>mpereira@francefoundation.com</itunes:email>
  </itunes:owner>
  <copyright>Copyright 2008 The France Foundation</copyright>
  <pubDate>Thu, 31 Jul 2008 01:00:00 EDT</pubDate>
  <lastBuildDate>Fri, 13 Nov 2009 01:00:00 EDT</lastBuildDate>
  <itunes:image href="http://www.hiteducation.com/podcast/HIT_album_art.gif" />
  <itunes:category text="Science &amp; Medicine">
    <itunes:category text="Medicine"/>
  </itunes:category>

<ttl>60</ttl>

<item>
  <title>Clinical perspectives on HIT diagnosis and management</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_06.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_06.mp3</guid>
  <itunes:summary>What are the barriers to increased awareness, accurate diagnosis, and effective management of HIT? What are some practical tips for HIT diagnosis and management in the critical care setting?</itunes:summary>
  <description>Utilize practical tools for raising HIT awareness and improving its management in the hospital setting.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_06.mp3" length="12004522" type="audio/mpeg"/>
  <pubDate>Fri, 13 Nov 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:12:30</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Acute and chronic management of HIT</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_05.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_05.mp3</guid>
  <itunes:summary>What are the first steps in managing suspected HIT? When is it appropriate to initiate alternative anticoagulants? What are the dangers in transitioning too rapidly to warfarin? What are the ACCP recommendations on warfarin and Vitamin K?</itunes:summary>
  <description>Review the most recent guidelines for the early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_05.mp3" length="15738569" type="audio/mpeg"/>
  <pubDate>Thu, 22 Oct 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:16:25</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Differentiating HIT from alternative causes of thrombocytopenia</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_04.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_04.mp3</guid>
  <itunes:summary>What are some alternate conditions that present with similar findings as HIT? What are the key factors that distinguish HIT from other causes of thrombocytopenia?</itunes:summary>
  <description>Review the most recent guidelines for the early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_04.mp3" length="6864878" type="audio/mpeg"/>
  <pubDate>Thu, 22 Oct 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:07:09</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Recent developments in HIT diagnostics comparing the ELISA OD assay with the serotonin release assay</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_03.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_03.mp3</guid>
  <itunes:summary>How are ELISA OD results used to assess the risk of HIT? What is a patient example of an ELISA OD assay result? Should positive/negative indicators or numerical values be used for reporting of ELISA OD assay results?</itunes:summary>
  <description>Review the most recent guidelines for the early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_03.mp3" length="14355960" type="audio/mpeg"/>
  <pubDate>Tue, 15 Sep 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:14:57</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Clinical presentation of HIT</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_02.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_02.mp3</guid>
  <itunes:summary>What are the clinical signs suggesting HIT? What are the AACP criteria for HIT diagnosis? What is the 4T system?</itunes:summary>
  <description>Review the most recent guidelines for the early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_02.mp3" length="15602314" type="audio/mpeg"/>
  <pubDate>Tue, 15 Sep 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:16:15</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Incidence, Risk Factors and Timing of HIT</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_01.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_01.mp3</guid>
  <itunes:summary>How common is HIT in the hospital setting? What are the risk factors that should make us suspect HIT? How long after heparin exposure can HIT occur?</itunes:summary>
  <description>Identify risk factors associated with heparin-induced thrombocytopenia (HIT) in the hospital setting and apply this knowledge toward guideline adherence for accurate HIT screening and identification</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_01.mp3" length="9113600" type="audio/mpeg"/>
  <pubDate>Thu, 06 Aug 2009 01:00:00 EDT</pubDate>
  <itunes:duration>00:09:29</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Management of HIT, Part 3 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Management_03.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Management_03.mp3</guid>
  <itunes:summary>What experimental drugs that would be useful for HIT management are in clinical testing? What are their anticipated benefits and risks?</itunes:summary>
  <description>Discuss current guidelines and specific therapies in the management of and possible prevention of HIT</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Management_03.mp3" length="9910893" type="audio/mpeg"/>
  <pubDate>Tue, 09 Dec 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:13:02</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Management of HIT, Part 2 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Management_02.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Management_02.mp3</guid>
  <itunes:summary>When should different anticoagulants such as heparin, direct thrombin inhibitors, and warfarin be used in managing HIT or suspected HIT?</itunes:summary>
  <description>Discuss current guidelines and specific therapies in the management of and possible prevention of HIT</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Management_02.mp3" length="9910893" type="audio/mpeg"/>
  <pubDate>Wed, 05 Nov 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:10:19</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Management of HIT, Part 1 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Management_01.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Management_01.mp3</guid>
  <itunes:summary>What are the relevant guidelines for HIT management and which recommendations deviate from traditional practice? In which health care settings is HIT effectively recognized and how can health care providers be more aware of HIT?</itunes:summary>
  <description>Discuss current guidelines and specific therapies in the management of and possible prevention of HIT</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Management_01.mp3" length="12492123" type="audio/mpeg"/>
  <pubDate>Tue, 30 Sep 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:13:00</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Recognition and Diagnosis of HIT, Part 3 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_03.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_03.mp3</guid>
  <itunes:summary>What is measured by the ELISA and serotonin release antibody tests, what is their pathophysiological relevance, and how should the results be used in diagnosing HIT?</itunes:summary>
  <description>Identify risk factors associated with HIT and describe criteria or current guidelines for early recognition and appropriate diagnosis of HIT. Discuss current guidelines and specific therapies in the management of and possible prevention of HIT.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Diagnosis_03.mp3" length="14472456" type="audio/mpeg"/>
  <pubDate>Thu, 04 Sep 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:15:04</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Recognition and Diagnosis of HIT, Part 2 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_02.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_02.mp3</guid>
  <itunes:summary>What is a typical time between initiation of heparin therapy and onset of HIT and what are the physiological mechanisms that determine longer or shorter onset times?</itunes:summary>
  <description>Identify risk factors associated with HIT and describe criteria or current guidelines for early recognition and appropriate diagnosis of HIT. Discuss current guidelines and specific therapies in the management of and possible prevention of HIT.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Diagnosis_02.mp3" length="11325774" type="audio/mpeg"/>
  <pubDate>Thu, 07 Aug 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:11:49</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

<item>
  <title>Recognition and Diagnosis of HIT, Part 1 of 3</title>
  <itunes:author>HITeducation.com</itunes:author>
  <link>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_01.mp3</link>
  <guid>http://www.HITeducation.com/podcast/HITeducation_Diagnosis_01.mp3</guid>
  <itunes:summary>What are the risk factors for HIT? How can the 4T system be used to help diagnose HIT?</itunes:summary>
  <description>Identify risk factors associated with HIT and describe criteria or current guidelines for early recognition and appropriate diagnosis of HIT. Discuss current guidelines and specific therapies in the management of and possible prevention of HIT.</description>
  <category>CME - Peer-to-Peer Dialogue</category>
  <enclosure url="http://www.HITeducation.com/podcast/HITeducation_Diagnosis_01.mp3" length="16739268" type="audio/mpeg"/>
  <pubDate>Wed, 30 Jul 2008 01:00:00 EDT</pubDate>
  <itunes:duration>00:17:25</itunes:duration>
  <itunes:keywords>Clinical Update, HIT Trials, HIT education, CME Podcast, Heparin-Induced Thrombocytopenia, The France Foundation, HITeducation.com</itunes:keywords>
</item>

</channel>
</rss>
